Disease | demyelinating disease |
Phenotype | C0035435|rheumatic disease |
Sentences | 2 |
PubMedID- 22152489 | Objectives: to estimate the rate of demyelinating diseases in patients with rheumatic diseases treated with tumor necrosis factor (tnf) antagonists and to describe the cases reported to 3 different pharmacovigilance sources. |
PubMedID- 20864146 | The incidence rate of demyelinating disease in patients with rheumatic diseases exposed to tnf antagonists in biobadaser was 0.65 per 1000 patient-years (95%ci: 0.39-1.1). |
Page: 1